DIPB vs. SIFIB for Postoperative Analgesia After Hip Surgery
Comparison of the Effects of Deep Iliacus Plane Block (DIPB) and Suprainguinal Fascia Iliaca Block (SIFIB) on Postoperative Analgesia in Patients Undergoing Hip Surgery: A Randomized Controlled Study
1 other identifier
interventional
70
1 country
2
Brief Summary
This randomized, double-blind clinical trial aims to compare the effectiveness of the Deep Iliacus Plane Block (DIPB) and the Suprainguinal Fascia Iliaca Block (SIFIB) for postoperative pain control in patients undergoing primary total hip arthroplasty. Effective analgesia after hip surgery is essential for early mobilization, reduction of complications, and improved recovery outcomes. Seventy patients scheduled for elective hip arthroplasty under spinal anesthesia will be randomly assigned to receive either DIPB or SIFIB at the end of surgery. Postoperative pain scores, opioid consumption, motor block, and block-related complications will be evaluated over a 48-hour period. The study aims to determine whether DIPB provides superior or comparable analgesia with reduced motor blockade compared to SIFIB, thereby contributing to safer and more comprehensive postoperative pain management in hip surgery patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Mar 2026
Shorter than P25 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 23, 2026
CompletedFirst Posted
Study publicly available on registry
March 5, 2026
CompletedStudy Start
First participant enrolled
March 27, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
November 1, 2026
April 2, 2026
March 1, 2026
6 months
February 23, 2026
March 28, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Postoperative pain intensity
Postoperative pain assessed using the Numeric Rating Scale (NRS; 0 = no pain, 10 = worst pain imaginable) at rest and during movement following total hip arthroplasty.
2, 4, 8, 16, 24, and 48 hours postoperatively
Secondary Outcomes (3)
Opioid consumption
From the end of surgery to 48 hours postoperatively
Motor block
4, 8, 16, 24, and 48 hours postoperatively
Pain during movement
2, 4, 8, 16, 24, and 48 hours postoperatively
Study Arms (2)
Suprainguinal Fascia Iliaca Block (SIFIB)
EXPERIMENTALParticipants randomized to this arm will receive an ultrasound-guided suprainguinal fascia iliaca compartment block at the end of surgery using 0.25% bupivacaine (30-40 mL, weight-adjusted) for postoperative analgesia following primary total hip arthroplasty.
Deep Iliacus Plane Block (DIPB)
EXPERIMENTALParticipants randomized to this arm will receive an ultrasound-guided deep iliacus plane block at the end of surgery using 0.25% bupivacaine (30-40 mL, weight-adjusted) for postoperative analgesia following primary total hip arthroplasty.
Interventions
Ultrasound-guided suprainguinal fascia iliaca compartment block performed at the end of surgery using 0.25% bupivacaine (30-40 mL, weight-adjusted) for postoperative analgesia following primary total hip arthroplasty.
Ultrasound-guided deep iliacus plane block performed at the end of surgery using 0.25% bupivacaine (30-40 mL, weight-adjusted) for postoperative analgesia following primary total hip arthroplasty.
Eligibility Criteria
You may qualify if:
- Patients aged ≥18 years
- ASA physical status I-III
- Scheduled for elective primary total hip arthroplasty under spinal anesthesia
- Ability to understand the study procedures and provide informed consent
You may not qualify if:
- Coagulation disorders or anticoagulant therapy contraindicating regional anesthesia
- Infection at the block application site
- Hemodynamic instability
- Known allergy to local anesthetics
- Pre-existing significant neurological or motor deficits in the lower extremities
- Cognitive impairment preventing pain assessment
- Refusal to participate or inability to provide informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Sivas Numune Hospital
Sivas, Sivas, 58050, Turkey (Türkiye)
Sivas Numune Hospital
Sivas, Turkey (Türkiye)
Related Publications (4)
Tulgar S, Ciftci B, Koyuncu B, Ahiskalioglu A, Alver S, Bilal B, Sakul BU, Otu E, Narayanan M, Alici HA. Ultrasound-guided Deep Iliacus Plane Block (DIPB): Cadaveric Evaluation and Pilot Retrospective Evaluation of Another Novel Fascial Plane Block for Hip Analgesia. Turk J Anaesthesiol Reanim. 2026 Feb 9;54(1):55-61. doi: 10.4274/TJAR.2025.252252. Epub 2026 Jan 7.
PMID: 41498358BACKGROUNDSekhon J, Jain R, Bansal K, Luthra N, Singh MR, Kumari B. Efficacy of Different Volumes of 0.2% Ropivacaine in Suprainguinal Fascia Iliaca Compartment Block for Multimodal Analgesia in Lower Limb Surgery. Cureus. 2023 Oct 12;15(10):e46894. doi: 10.7759/cureus.46894. eCollection 2023 Oct.
PMID: 37954742BACKGROUNDLee S, Hwang JM, Lee S, Eom H, Oh C, Chung W, Ko YK, Lee W, Hong B, Hwang DS. Implementation of the Obturator Nerve Block into a Supra-Inguinal Fascia Iliaca Compartment Block Based Analgesia Protocol for Hip Arthroscopy: Retrospective Pre-Post Study. Medicina (Kaunas). 2020 Mar 27;56(4):150. doi: 10.3390/medicina56040150.
PMID: 32230895BACKGROUNDSaeaeh L, Chalacheewa T, Lerdwimonsak C, Phurikamonarunothai S. Comparison between combined suprainguinal fascia iliaca compartment block with intra-articular bupivacaine and suprainguinal fascia iliaca compartment block in total hip arthroplasty: randomized double blinded controlled trial. BMC Anesthesiol. 2025 Sep 29;25(1):461. doi: 10.1186/s12871-025-03345-y.
PMID: 41023795BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Fatih BALCI
Sivas Numune Hospital, Department of Anesthesiology and Reanimation
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Specialist physician
Study Record Dates
First Submitted
February 23, 2026
First Posted
March 5, 2026
Study Start
March 27, 2026
Primary Completion (Estimated)
October 1, 2026
Study Completion (Estimated)
November 1, 2026
Last Updated
April 2, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share